EC Number   |
Activating Compound |
Reference |
|---|
    3.5.3.1 | 1-amino-6-methyl-4-phenyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid methyl ester |
activity is enhanced in the presence of the dihydropyrimidine derivative |
753792 |
| 3.5.3.1 | cysteine |
effect of cysteine on arginase activity, effect of increasing concentrations of cysteine alone or in combination with iron (II) sulfate on the enhancement of arginase activity in human sickle erythrocytes or purified arginase-1 from Bos taurus liver |
696006 |
| 3.5.3.1 | dexamethasone |
augments arginase activity in Actinobacillus actinomycetemcomitans-lipopolysaccharide-stimulated cells |
689301 |
| 3.5.3.1 | FeSO4 |
effect of cysteine on arginase activity, effect of increasing concentrations of cysteine alone or in combination with iron (II) sulfate on the enhancement of arginase activity in human sickle erythrocytes or purified arginase-1 from Bos taurus liver |
696006 |
| 3.5.3.1 | hydralazine |
treatment with 20 mg/kg/day hydralazine for 5 weeks causes increased arginase activity in hypertensive rats |
688758 |
| 3.5.3.1 | IL-4 |
interleukin IL-4, up to 16-fold stimulation of enzyme activity in RAW-264.7 cell, in combinantion with rolipram additional activation. No stimulation of enzyme in alveolar macrophages by IL-4 alone, but increase of stimulation by forskolin and 3-isobutyl-1-methylxanthine, IBMX, in presence of IL-4 |
667160 |
| 3.5.3.1 | interleukin-4 |
augments arginase activity in Actinobacillus actinomycetemcomitans-lipopolysaccharide-stimulated cells |
689301 |
| 3.5.3.1 | L-arginine |
strong substrate activation of the kidney enzyme at concentrations above 4 mM |
656441 |
| 3.5.3.1 | L-arginine |
the enzyme is kinetically cooperative and the commonly detected hyperbolic behavior results from binding of L-arginine as a typical allosteric activator |
752843 |
| 3.5.3.1 | lipopolysaccharide |
0.001 mg/ml cause a 2fold increase in arginase activity and a marked increase in mRNA encoding arginase I |
686562 |
